Reza Shahbazi PhD

Dr. Reza Shahbazi is an Assistant Professor in the Department of Medicine, Division of Hematology/Oncology at Indiana University School of Medicine, and joined as an active member of the Brown Center for Immunotherapy in 2021. Dr. Reza Shahbazi earned his Ph.D. in Nanotechnology and Nanomedicine in 2017 from Hacettepe University, in Ankara, Turkey, where he worked on developing siRNA nanotherapeutics for triple-negative breast cancer therapy. Then continued his research as a Postdoctoral Fellow in the field of Stem Cell Gene Editing at the Fred Hutchinson Cancer Research Center in Seattle.

During his Postdoc, Dr. Shahbazi worked on developing CRISPR nanoformulations for in vivo gene editing in hematopoietic stem cells and T cells as a cure for HIV and beta thalassemia. His research in this field has received a lot of attention and has been broadcast on different media. Dr. Shahbazi is an active member of the American Society of Gene & Cell Therapy (ASGCT) and has received a meritorious award from the society. His scientific work has resulted in multiple patents that have been licensed.